David Bredt serves as Executive at Rapport Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, David Bredt has executed 11 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved selling 796 shares valued at $24.4K.
David Bredt currently holds 392,642 shares of Rapport Therapeutics, Inc. (RAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Bredt has been a net seller of RAPP stock. They have purchased $0 and sold $1.1M worth of shares.
David Bredt's most recent insider trade was on Dec 15, 2025, when they sold 796 shares at $30.68 per share.
Get notified when new Form 4 filings are submitted
| $29.95 |
| Discretionary |
| Nov 17, 2025 | RAPP | $78.4K | Sale | 3,156 | $24.84 | Discretionary |
| Nov 17, 2025 | RAPP | $135.7K | Sale | 5,344 | $25.39 | Discretionary |
| Oct 15, 2025 | RAPP | $190.9K | Sale | 7,418 | $25.73 | Discretionary |
| Oct 15, 2025 | RAPP | $28.3K | Sale | 1,082 | $26.16 | Discretionary |
| Sep 15, 2025 | RAPP | $83.9K | Sale | 3,402 | $24.66 | Discretionary |
| Sep 15, 2025 | RAPP | $121.7K | Sale | 5,098 | $23.88 | Discretionary |
| Aug 15, 2025 | RAPP | $3.2K | Sale | 200 | $15.79 | Discretionary |
| Aug 15, 2025 | RAPP | $124.3K | Sale | 8,300 | $14.98 | Discretionary |
| Jul 15, 2025 | RAPP | $119.0K | Sale | 8,500 | $14.00 | Discretionary |